Trulieve Cannabis is trading 14.02% lower at $10.67 after a DEA judge paused the remaining marijuana-rescheduling case on September 29, delaying a recommendation investors viewed as a near-term catalyst.
- The judge is considering whether to add a Government Accountability Office report to the hearing record.
- The DEA must respond by October 13.
- The pause delays proceedings but does not reject rescheduling.